The severity of inflammation in major neuropsychiatric disorders: comparison of neutrophil–lymphocyte and platelet–lymphocyte ratios between schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and obsessive compulsive disorder

References

• Bray NJ, O’Donovan MC. The genetics of neuropsychiatric disorders. Brain Neurosci Adv. 2018;2.
   Google Scholar
• Hyman SE. A glimmer of light for neuropsychiatric disorders. Nature. 2008;455(7215):890–893.
   PubMed Web of Science ®Google Scholar
• Zhang J, Harvey C, Andrew C. Factors associated with length of stay and the risk of readmission in an acute psychiatric inpatient facility: a retrospective study. Aust N Z J Psychiatry. 2011;45(7):578–585.
   PubMed Web of Science ®Google Scholar
• Alosaimi FD, Alzain N, Asiri S, et al., Patterns of psychiatric diagnoses in inpatient and outpatient psychiatric settings in Saudi Arabia. Arch Clin Psychiatry (São Paulo). 2017;44(3):77–83.
   Google Scholar
• Allan SM, Rothwell NJ. Cytokines and acute neurodegeneration. Nat Rev Neurosci. 2001;2(10):734–744.
   PubMed Web of Science ®Google Scholar
• Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry. 2008;64(6):527–532.
   PubMed Web of Science ®Google Scholar
• Pollak TA, Drndarski S, Stone JM, et al. The blood–brain barrier in psychosis. Lancet Psychiatry. 2018;5(1):79–92.
   PubMed Web of Science ®Google Scholar
• Réus GZ, Fries GR, Stertz L, et al. The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders. Neuroscience. 2015;300:141–154.
   PubMed Web of Science ®Google Scholar
• Hassan W, Noreen H, Castro-Gomes V, et al. Association of oxidative stress with psychiatric disorders. Curr Pharm Des. 2016;22(20):2960–2974.
   PubMed Web of Science ®Google Scholar
• Bauer ME, Teixeira AL. Inflammation in psychiatric disorders: what comes first? Ann N Y Acad Sci. 2019;1437(1):57–67.
   PubMed Web of Science ®Google Scholar
• Gray SM, Bloch MH. Systematic review of proinflammatory cytokines in obsessive-compulsive disorder. Curr Psychiatry Rep. 2012;14(3):220–228.
   PubMed Web of Science ®Google Scholar
• Madore C, Leyrolle Q, Lacabanne C, et al. Neuroinflammation in autism: plausible role of maternal inflammation, dietary omega 3, and microbiota. Neural Plast. 2016;2016:3597209.
   PubMed Web of Science ®Google Scholar
• Leffa DT, Torres IL, Rohde LA. A review on the role of inflammation in attention-deficit/hyperactivity disorder. Neuroimmunomodulation. 2018;25(5–6):328–333.
   PubMed Web of Science ®Google Scholar
• Guthrie GJK, Charles KA, Roxburgh CSD, et al. The systemic inflammation-based neutrophil–lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–230.
   PubMed Web of Science ®Google Scholar
• Wright HL, Moots RJ, Bucknall RC, et al. Neutrophil function in inflammation and inflammatory diseases. Rheumatology (Oxford). 2010;49(9):1618–1631.
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002;22(9):913–922.
   PubMed Web of Science ®Google Scholar
• Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratislavske Lekarske Listy. 2001;102(1):5–14.
   PubMedGoogle Scholar
• Zulfic Z, Weickert CS, Weickert TW, et al. Neutrophil–lymphocyte ratio – a simple, accessible measure of inflammation, morbidity and prognosis in psychiatric disorders? Australas Psychiatry. 2020;28(4):454–458.
   PubMed Web of Science ®Google Scholar
• Walsh SR, Cook EJ, Goulder F, et al. Neutrophil–lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91(3):181–184.
   PubMed Web of Science ®Google Scholar
• Mazza MG, Lucchi S, Tringali AGM, et al. Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: a meta-analysis. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;84:229–236.
   PubMed Web of Science ®Google Scholar
• Howard R, Scheiner A, Kanetsky PA, et al. Sociodemographic and lifestyle factors associated with the neutrophil-to-lymphocyte ratio. Ann Epidemiol. 2019;38:11–21.e6.
   PubMed Web of Science ®Google Scholar
• Jacomb I, Stanton C, Vasudevan R, et al. C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol. 2018;9:2230.
   PubMed Web of Science ®Google Scholar
• Chandrashekara S, Mukhtar Ahmad M, Renuka P, et al. Characterization of neutrophil-to-lymphocyte ratio as a measure of inflammation in rheumatoid arthritis. Int J Rheum Dis. 2017;20(10):1457–1467.
   PubMed Web of Science ®Google Scholar
• Fu H, Qin B, Hu Z, et al. Neutrophil- and platelet-to-lymphocyte ratios are correlated with disease activity in rheumatoid arthritis. Clin Lab. 2015;61(3–4):269–273.
   PubMed Web of Science ®Google Scholar
• Taylan M, Demir M, Kaya H, et al. Alterations of the neutrophil–lymphocyte ratio during the period of stable and acute exacerbation of chronic obstructive pulmonary disease patients. Clin Respir J. 2017;11(3):311–317.
   PubMed Web of Science ®Google Scholar
• Kim HW, Lee J-c, Paik K-h, et al. Serum interleukin-6 is associated with pancreatic ductal adenocarcinoma progression pattern. Medicine. 2017;96(5):e5926.
   PubMed Web of Science ®Google Scholar
• Azab B, Jaglall N, Atallah JP, et al. Neutrophil–lymphocyte ratio as a predictor of adverse outcomes of acute pancreatitis. Pancreatology. 2011;11(4):445–452.
   PubMed Web of Science ®Google Scholar
• Bhat T, Teli S, Rijal J, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013;11(1):55–59.
   PubMedGoogle Scholar
• Qin B, Ma N, Tang Q, et al. Neutrophil to lymphocyte ratio (NLR) and platelet to lymphocyte ratio (PLR) were useful markers in assessment of inflammatory response and disease activity in SLE patients. Mod Rheumatol. 2016;26(3):372–376.
   PubMed Web of Science ®Google Scholar
• Kuyumcu ME, Yesil Y, Oztürk ZA, et al. The evaluation of neutrophil–lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34(2):69–74.
   PubMed Web of Science ®Google Scholar
• Semiz M, Yildirim O, Canan F, et al. Elevated neutrophil/lymphocyte ratio in patients with schizophrenia. Psychiatr Danub. 2014;26(3):220–225.
   PubMed Web of Science ®Google Scholar
• Kulaksizoglu B, Kulaksizoglu S. Relationship between neutrophil/lymphocyte ratio with oxidative stress and psychopathology in patients with schizophrenia. Neuropsychiatr Dis Treat. 2016;12:1999–2005.
   PubMed Web of Science ®Google Scholar
• Demir S, Atli A, Bulut M, et al. Neutrophil–lymphocyte ratio in patients with major depressive disorder undergoing no pharmacological therapy. Neuropsychiatr Dis Treat. 2015;11:2253.
   PubMed Web of Science ®Google Scholar
• Kayhan F, Gündüz Ş, Ersoy SA, et al. Relationships of neutrophil–lymphocyte and platelet–lymphocyte ratios with the severity of major depression. Psychiatry Res. 2017;247:332–335.
   PubMed Web of Science ®Google Scholar
• Giynas Ayhan M, Cicek IE, Inanli I, et al. Neutrophil/lymphocyte and platelet/lymphocyte ratios in all mood states of bipolar disorder. Psychiatry Clin Psychopharmacol. 2017;27(3):278–282.
   Web of Science ®Google Scholar
• Avcil S. Evaluation of the neutrophil/lymphocyte ratio, platelet/lymphocyte ratio, and mean platelet volume as inflammatory markers in children with attention-deficit hyperactivity disorder. Psychiatry Clin Neurosci. 2018;72(7):522–530.
   PubMed Web of Science ®Google Scholar
• Özyurt G, Binici NC. The neutrophil–lymphocyte ratio and platelet–lymphocyte ratio in adolescent obsessive-compulsive disorder: does comorbid anxiety disorder affect inflammatory response? Psychiatry Res. 2019;272:311–315.
   PubMed Web of Science ®Google Scholar
• Herdi O, Sayar-Akaslan D, İlhan RS, et al. Associations between subclinical inflammatory markers and OCD: a retrospective study. Psychiatry Res. 2020;290:113065.
   PubMed Web of Science ®Google Scholar
• Tural Hesapcioglu S, Kasak M, Cıtak Kurt AN, et al. High monocyte level and low lymphocyte to monocyte ratio in autism spectrum disorders. Int J Dev Disabil. 2019;65(2):73–81.
   Web of Science ®Google Scholar
• Rothschild AJ. Challenges in the treatment of major depressive disorder with psychotic features. Schizophr Bull. 2013;39(4):787–796.
   PubMed Web of Science ®Google Scholar
• Kempf L, Hussain N, Potash JB. Mood disorder with psychotic features, schizoaffective disorder, and schizophrenia with mood features: trouble at the borders. Int Rev Psychiatry. 2005;17(1):9–19.
   PubMed Web of Science ®Google Scholar
• Domschke K. Clinical and molecular genetics of psychotic depression. Schizophr Bull. 2013;39(4):766–775.
   PubMed Web of Science ®Google Scholar
• Cummings JL, Miller B, Hill MA, et al. Neuropsychiatric aspects of multi-infarct dementia and dementia of the Alzheimer type. Arch Neurol. 1987;44(4):389–393.
   PubMedGoogle Scholar
• Busatto GF. Structural and functional neuroimaging studies in major depressive disorder with psychotic features: a critical review. Schizophr Bull. 2013;39(4):776–786.
   PubMed Web of Science ®Google Scholar
• Kalelioglu T, Akkus M, Karamustafalioglu N, et al. Neutrophil–lymphocyte and platelet–lymphocyte ratios as inflammation markers for bipolar disorder. Psychiatry Res. 2015;228(3):925–927.
   PubMed Web of Science ®Google Scholar
• Tsai S-YM, Yang Y-Y, Kuo C-J, et al. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord. 2001;64(2–3):185–193.
   PubMed Web of Science ®Google Scholar
• Tsai S-Y, Chung K-H, Wu J-Y, et al. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord. 2012;136(1–2):110–116.
   PubMed Web of Science ®Google Scholar
• Mukherjee D, Krishnamurthy VB, Millett CE, et al. Total sleep time and kynurenine metabolism associated with mood symptom severity in bipolar disorder. Bipolar Disord. 2018;20(1):27–34.
   PubMed Web of Science ®Google Scholar
• Dickerson F, Stallings C, Origoni A, et al. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(4):952–955.
   PubMed Web of Science ®Google Scholar
• Rosenblat JD, McIntyre RS. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 2017;7(12):144.
   PubMed Web of Science ®Google Scholar
• Cunha ÂB, Andreazza AC, Gomes FA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2008;258(5):300–304.
   PubMed Web of Science ®Google Scholar
• Bai Y-M, Su T-P, Tsai S-J, et al. Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J Affect Disord. 2014;166:187–192.
   PubMed Web of Science ®Google Scholar
• Wang T-Y, Lee S-Y, Chen S-L, et al. The differential levels of inflammatory cytokines and BDNF among bipolar spectrum disorders. Int J Neuropsychopharmacol. 2016;19(8):pyw012.
   PubMed Web of Science ®Google Scholar
• Sayana P, Colpo GD, Simões LR, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017;92:160–182.
   PubMed Web of Science ®Google Scholar
• Yüksel RN, Ertek IE, Dikmen AU, et al. High neutrophil–lymphocyte ratio in schizophrenia independent of infectious and metabolic parameters. Nord J Psychiatry. 2018;72(5):336–340.
   PubMed Web of Science ®Google Scholar
• Özdin S, Böke Ö. Neutrophil/lymphocyte, platelet/lymphocyte and monocyte/lymphocyte ratios in different stages of schizophrenia. Psychiatry Res. 2019;271:131–135.
   PubMed Web of Science ®Google Scholar
• Özdin S, Sarisoy G, Böke Ö. A comparison of the neutrophil–lymphocyte, platelet–lymphocyte and monocyte–lymphocyte ratios in schizophrenia and bipolar disorder patients – a retrospective file review. Nord J Psychiatry. 2017;71(7):509–512.
   PubMed Web of Science ®Google Scholar
• Jablensky A. Subtyping schizophrenia: implications for genetic research. Mol Psychiatry. 2006;11(9):815–836.
   PubMed Web of Science ®Google Scholar
• Zhang T, Koutsouleris N, Meisenzahl E, et al. Heterogeneity of structural brain changes in subtypes of schizophrenia revealed using magnetic resonance imaging pattern analysis. Schizophr Bull. 2015;41(1):74–84.
   PubMed Web of Science ®Google Scholar
• Albus M. Clinical courses of schizophrenia. Pharmacopsychiatry. 2012;45(Suppl. 1):S31–S35.
   PubMedGoogle Scholar
• Miller BJ, Buckley P, Seabolt W, et al. Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry. 2011;70(7):663–671.
   PubMed Web of Science ®Google Scholar
• Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci. 2019;44:49–66.
   Google Scholar
• Demircan F, Gözel N, Kılınç F, et al. The impact of red blood cell distribution width and neutrophil/lymphocyte ratio on the diagnosis of major depressive disorder. Neurol Ther. 2016;5(1):27–33.
   PubMed Web of Science ®Google Scholar
• Aydin Sunbul E, Sunbul M, Yanartas O, et al. Increased neutrophil/lymphocyte ratio in patients with depression is correlated with the severity of depression and cardiovascular risk factors. Psychiatry Investig. 2016;13(1):121.
   PubMed Web of Science ®Google Scholar
• Ekinci O, Ekinci A. The connections among suicidal behavior, lipid profile and low-grade inflammation in patients with major depressive disorder: a specific relationship with the neutrophil-to-lymphocyte ratio. Nord J Psychiatry. 2017;71(8):574–580.
   PubMed Web of Science ®Google Scholar
• Jokela M, Virtanen M, Batty GD, et al. Inflammation and specific symptoms of depression. JAMA Psychiatry. 2016;73(1):87–88.
   PubMed Web of Science ®Google Scholar
• Griffiths CEM, Fava M, Miller AH, et al. Impact of ixekizumab treatment on depressive symptoms and systemic inflammation in patients with moderate-to-severe psoriasis: an integrated analysis of three phase 3 clinical studies. Psychother Psychosom. 2017;86(5):260–267.
   PubMed Web of Science ®Google Scholar
• Sun Y, Wang D, Salvadore G, et al. The effects of interleukin-6 neutralizing antibodies on symptoms of depressed mood and anhedonia in patients with rheumatoid arthritis and multicentric Castleman's disease. Brain Behav Immun. 2017;66:156–164.
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, Buttenschøn HN, Tansey KE, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344–350.
   PubMed Web of Science ®Google Scholar
• Slavich GM, Irwin MR. From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull. 2014;140(3):774–815.
   PubMed Web of Science ®Google Scholar
• Köhler-Forsberg O, Lydholm N, Hjorthøj C, et al. Efficacy of anti-inflammatory treatment on major depressive disorder or depressive symptoms: meta-analysis of clinical trials. Acta Psychiatr Scand. 2019;139(5):404–419.
   PubMed Web of Science ®Google Scholar
• Atmaca M, Kilic F, Koseoglu F, et al. Neutrophils are decreased in obsessive-compulsive disorder: preliminary investigation. Psychiatry Investig. 2011;8(4):362–365.
   PubMed Web of Science ®Google Scholar
• Uzun AD, Yalın Sapmaz Ş, Çakır B, et al. Could neutrophil-to-lymphocyte ratio be an important parameter in children and adolescents with obsessive compulsive disorder? J Clin Psychiatry. 2020;23(1):101–105.
   Web of Science ®Google Scholar
• Attwells S, Setiawan E, Wilson AA, et al. Inflammation in the neurocircuitry of obsessive-compulsive disorder. JAMA Psychiatry. 2017;74(8):833–840.
   PubMed Web of Science ®Google Scholar
• Rao NP, Venkatasubramanian G, Ravi V, et al. Plasma cytokine abnormalities in drug-naïve, comorbidity-free obsessive-compulsive disorder. Psychiatry Res. 2015;229(3):949–952.
   PubMed Web of Science ®Google Scholar
• Wysokiński A, Margulska A, Strzelecki D, et al. Levels of C-reactive protein (CRP) in patients with schizophrenia, unipolar depression and bipolar disorder. Nord J Psychiatry. 2015;69(5):346–353.
   PubMed Web of Science ®Google Scholar
• Goldsmith D, Rapaport M, Miller B. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696–1709.
   PubMed Web of Science ®Google Scholar